Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas Treatment.

Trial Profile

Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2013

At a glance

  • Drugs Tamsulosin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 25 Dec 2009 Actual patient number (900) added as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jul 2009 Actual initiation date changed from Dec 2008 to Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top